메뉴 건너뛰기




Volumn 32, Issue 1, 2012, Pages 1-3

Sildenafil therapy for bronchopulmonary dysplasia: Not quite yet

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; NITRIC OXIDE; PLACEBO; SILDENAFIL;

EID: 84855267436     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2011.158     Document Type: Editorial
Times cited : (10)

References (32)
  • 3
  • 4
    • 48449101584 scopus 로고    scopus 로고
    • Nonventilatory strategies for prevention and treatment of bronchopulmonary dysplasiaFwhat is the evidence?
    • Thomas W, Speer CP. Nonventilatory strategies for prevention and treatment of bronchopulmonary dysplasiaFwhat is the evidence? Neonatology 2008; 94(3): 150-159.
    • (2008) Neonatology , vol.94 , Issue.3 , pp. 150-159
    • Thomas, W.1    Speer, C.P.2
  • 5
    • 0038132958 scopus 로고    scopus 로고
    • A comparison of three vitamin a dosing regimens in extremely-low-birth- weight infants
    • DOI 10.1067/mpd.2003.214
    • Ambalavanan N, Wu TJ, Tyson JE, Kennedy KA, Roane C, Carlo WA. A comparison of three vitamin A dosing regimens in extremely-low-birth-weight infants. J Pediatr 2003; 142(6): 656-661. (Pubitemid 36737169)
    • (2003) Journal of Pediatrics , vol.142 , Issue.6 , pp. 656-661
    • Ambalavanan, N.1    Wu, T.-J.2    Tyson, J.E.3    Kennedy, K.A.4    Roane, C.5    Carlo, W.A.6
  • 9
    • 0033600279 scopus 로고    scopus 로고
    • Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network
    • Tyson JE, Wright LL, Oh W, Kennedy KA, Mele L, Ehrenkranz RA et al. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 1999; 340(25): 1962-1968.
    • (1999) N Engl J Med , vol.340 , Issue.25 , pp. 1962-1968
    • Tyson, J.E.1    Wright, L.L.2    Oh, W.3    Kennedy, K.A.4    Mele, L.5    Ehrenkranz, R.A.6
  • 10
    • 0032714191 scopus 로고    scopus 로고
    • Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants
    • Watterberg KL, Gerdes JS, Gifford KL, Lin HM. Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics 1999; 104: 1258-1263.
    • (1999) Pediatrics , vol.104 , pp. 1258-1263
    • Watterberg, K.L.1    Gerdes, J.S.2    Gifford, K.L.3    Lin, H.M.4
  • 12
    • 0344375086 scopus 로고    scopus 로고
    • Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase
    • DOI 10.1542/peds.111.3.469
    • Davis JM, Parad RB, Michele T, Allred E, Price A, Rosenfeld W. Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics 2003; 111(3): 469-476. (Pubitemid 36330700)
    • (2003) Pediatrics , vol.111 , Issue.3 , pp. 469-476
    • Davis, J.M.1    Parad, R.B.2    Michele, T.3    Allred, E.4    Price, A.5    Rosenfeld, W.6
  • 13
    • 77951012266 scopus 로고    scopus 로고
    • Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia
    • An HS, Bae EJ, Kim GB, Kwon BS, Beak JS, Kim EK et al. Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Korean Circ J 2010; 40(3): 131-136.
    • (2010) Korean Circ J. , vol.40 , Issue.3 , pp. 131-136
    • An, H.S.1    Bae, E.J.2    Kim, G.B.3    Kwon, B.S.4    Beak, J.S.5    Kim, E.K.6
  • 15
    • 36849067910 scopus 로고    scopus 로고
    • Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: Clinical features and outcomes in the surfactant era
    • DOI 10.1542/peds.2007-0971
    • Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: Clinical features and outcomes in the surfactant era. Pediatrics 2007; 120(6): 1260-1269. (Pubitemid 350223677)
    • (2007) Pediatrics , vol.120 , Issue.6 , pp. 1260-1269
    • Khemani, E.1    McElhinney, D.B.2    Rhein, L.3    Andradeb, O.4    Lacro, R.V.5    Thomas, K.C.6    Mullen, M.P.7
  • 16
    • 79960695146 scopus 로고    scopus 로고
    • Risk factors for pulmonary artery hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia
    • Kim DH, Kim HS, Choi CW, Kim EK, Kim BI, Choi JH. Risk factors for pulmonary artery hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia. Neonatology 2011; 101(1): 40-46.
    • (2011) Neonatology , vol.101 , Issue.1 , pp. 40-46
    • Kim, D.H.1    Kim, H.S.2    Choi, C.W.3    Kim, E.K.4    Kim, B.I.5    Choi, J.H.6
  • 17
    • 43049154418 scopus 로고    scopus 로고
    • The IUGR newborn
    • DOI 10.1053/j.semperi.2007.11.003, PII S0146000507001371
    • Rosenberg A. The IUGR newborn. Semin Perinatol 2008; 32(3): 219-224. (Pubitemid 351636317)
    • (2008) Seminars in Perinatology , vol.32 , Issue.3 , pp. 219-224
    • Rosenberg, A.1
  • 18
    • 82855181149 scopus 로고    scopus 로고
    • Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep
    • doi:10.1152/ajplung.00197.2011, e-pub ahead of print)
    • Rozance PJ, Seedorf GJ, Brown A, Roe GB, O'Meara MC, Gien J et al. Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep. Am J Physiol Lung Cell Mol Physiol 2011 (doi:10.1152/ajplung.00197.2011, e-pub ahead of print).
    • (2011) Am J Physiol Lung Cell Mol Physiol
    • Rozance, P.J.1    Seedorf, G.J.2    Brown, A.3    Roe, G.B.4    O'Meara, M.C.5    Gien, J.6
  • 19
    • 34248384848 scopus 로고    scopus 로고
    • Bronchopulmonary dysplasia: Where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease
    • DOI 10.1164/rccm.200611-1660PP
    • Thebaud B, Abman SH. Bronchopulmonary dysplasia: Where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med. (Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review). 2007 175( 10) 978-985. (Pubitemid 46741748)
    • (2007) American Journal of Respiratory and Critical Care Medicine , vol.175 , Issue.10 , pp. 978-985
    • Thebaud, B.1    Abman, S.H.2
  • 21
    • 0025580530 scopus 로고
    • Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease
    • Hislop AA, Haworth SG. Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease. Pediatr Pulmonol 1990; 9(3): 152-161.
    • (1990) Pediatr Pulmonol , vol.9 , Issue.3 , pp. 152-161
    • Hislop, A.A.1    Haworth, S.G.2
  • 22
    • 60549109238 scopus 로고    scopus 로고
    • Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease
    • 384.e1-2
    • Mourani PM, Sontag MK, Ivy DD, Abman SH. Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. J Pediatr 2009; 154(3): 379-384, 384.e1-2.
    • (2009) J Pediatr , vol.154 , Issue.3 , pp. 379-384
    • Mourani, P.M.1    Sontag, M.K.2    Ivy, D.D.3    Abman, S.H.4
  • 23
    • 33746632171 scopus 로고    scopus 로고
    • Inhaled drugs for the prevention and treatment of bronchopulmonary dysplasia
    • DOI 10.1002/ppul.20467
    • Pantalitschka T, Poets CF. Inhaled drugs for the prevention and treatment of bronchopulmonary dysplasia. Pediatr Pulmonol 2006; 41(8): 703-708. (Pubitemid 44157352)
    • (2006) Pediatric Pulmonology , vol.41 , Issue.8 , pp. 703-708
    • Pantalitschka, T.1    Poets, C.F.2
  • 26
    • 7044232096 scopus 로고    scopus 로고
    • Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia
    • DOI 10.1164/rccm.200310-1483OC
    • Mourani PM, Ivy DD, Gao D, Abman SH. Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia. Am J Respir Crit Care Med 2004; 170: 1006-1013. (Pubitemid 39425698)
    • (2004) American Journal of Respiratory and Critical Care Medicine , vol.170 , Issue.9 , pp. 1006-1013
    • Mourani, P.M.1    Ivy, D.D.2    Gao, D.3    Abman, S.H.4
  • 27
    • 80052088060 scopus 로고    scopus 로고
    • Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: SUPER-2
    • (doi:10.1378/chest.10-0969, e-pub ahead of print)
    • Rubin LJ, Badesch DB, Fleming TR, Galie N, Simonneau G, Ghofrani HA et al. Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: SUPER-2. Chest 2011 (doi:10.1378/chest.10-0969, e-pub ahead of print).
    • (2011) Chest
    • Rubin, L.J.1    Badesch, D.B.2    Fleming, T.R.3    Galie, N.4    Simonneau, G.5    Ghofrani, H.A.6
  • 29
    • 33646343464 scopus 로고    scopus 로고
    • Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: A pilot randomized blinded study
    • DOI 10.1542/peds.2005-0523
    • Baquero H, Soliz A, Neira F, Venegas ME, Sola A. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: A pilot randomized blinded study. Pediatrics 2006; 117(4): 1077-1083. (Pubitemid 46071498)
    • (2006) Pediatrics , vol.117 , Issue.4 , pp. 1077-1083
    • Baquero, H.1    Soliz, A.2    Neira, F.3    Venegas, M.E.4    Sola, A.5
  • 30
    • 73949143640 scopus 로고    scopus 로고
    • Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension of the newborn
    • Steinhorn R, Kinsella J, Pierce C, Butrous G, Dilleen M, Oakes M et al. Intravenous Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension of the Newborn. J Pediatr 2009; 155(6): 841-847.
    • (2009) J Pediatr , vol.155 , Issue.6 , pp. 841-847
    • Steinhorn, R.1    Kinsella, J.2    Pierce, C.3    Butrous, G.4    Dilleen, M.5    Oakes, M.6
  • 31
    • 66649101483 scopus 로고    scopus 로고
    • Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury
    • de Visser YP, Walther FJ, Laghmani el H, Boersma H, van der Laarse A, Wagenaar GT. Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury. Respir Res 2009; 10: 30.
    • (2009) Respir Res , vol.10 , pp. 30
    • De Visser, Y.P.1    Walther, F.J.2    Laghmaniel, H.3    Boersma, H.4    Van Der Laarse, A.5    Wagenaar, G.T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.